Global ADME Toxicology Testing Market, By Technology, By Application, By Method, By Region & Segmental Insights Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-1001
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 9+
  • No. of Countries : 29
  • Views : 10072
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Global ADME Toxicology Testing Market, By Technology, By Application, By Method, By Region & Segmental Insights Trends and Forecast, 2023 – 2031

ADME Toxicology Testing assesses how drugs or chemicals are absorbed, distributed, metabolized, and excreted (ADME) in the body, along with their potential toxicity. It helps predict a substance’s safety and effectiveness by studying its pharmacokinetics and potential adverse effects, aiding drug development and regulatory approval processes. In terms of revenue, the global ADME toxicology testing market was worth US$ 8.48 Bn in 2022, anticipated to witness CAGR of 10.5% during 2023 – 2031.

Trends in the Global ADME Toxicology Testing Market

  • Presently, the ADME toxicology testing market is witnessing a surge in demand due to the continuous expansion of drug development efforts worldwide. Pharmaceutical companies are actively developing new drugs to combat emerging health challenges, including the ongoing global pandemic. This trend is driving the need for robust ADME toxicology testing to assess a drug candidate’s safety and efficacy profile comprehensively. As the pharmaceutical pipeline continues to grow, the current trend emphasizes the crucial role of ADME toxicology testing in accelerating the drug development process and ensuring the safety of potential medications.
  • Another prominent driver in the ADME toxicology testing market is the increasing regulatory stringency governing drug safety assessments. Regulatory authorities like the FDA are continually updating guidelines and requirements for drug approval, mandating more extensive ADME toxicology testing. This trend is characterized by the heightened scrutiny of pharmacokinetics and toxicological assessments during drug development. As regulatory standards evolve and become more stringent, the current trend underscores the necessity for advanced and reliable ADME toxicology testing methods to meet these regulatory demands and ensure compliance in the pharmaceutical industry.

Global ADME Toxicology Testing Market Revenue & Forecast, (US$ Million), 2015 – 2031

High throughput technology segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global ADME toxicology testing market during the forecast period. The growth is primarily driven by its ability to expedite drug screening processes. High Throughput methods enable the simultaneous assessment of numerous compounds, significantly reducing testing time. As of recent years, the pharmaceutical industry has seen a notable increase in drug candidates entering development pipelines, necessitating efficient screening techniques. For example, in 2021, the U.S. FDA approved an unprecedented quantity of new drugs. The current trend underscores the increasing reliance on High Throughput ADME testing to meet the industry’s demand for quicker, cost-effective drug evaluations, expediting the pace of drug discovery and development.

Systemic toxicity application segment had the highest share in the global ADME toxicology testing market in 2022. This segment focuses on evaluating how substances affect the entire body, ensuring comprehensive toxicity assessment. In recent years, regulatory bodies have emphasized rigorous systemic toxicity testing to ensure public health and safety. For example, in the European Union, REACH regulations mandate comprehensive toxicological evaluations. This reinforces the significance of systemic toxicity testing in drug development and chemical safety assessments, making it a cornerstone of ensuring product safety, regulatory compliance, and public well-being.

Asia Pacific is expected to witness the highest growth rate in the ADME toxicology testing market during the forecast period. The region is witnessing a surge in pharmaceutical and biotechnology research and development, making it a burgeoning hub for drug discovery. In recent years, Asia Pacific’s pharmaceutical market has been expanding significantly, with countries like China and India leading the way. For instance, in 2020, China was the third-largest pharmaceutical market globally. This growth is propelling the demand for ADME toxicology testing to ensure safe and effective drug development. The current trend underscores the region’s increasing contribution to global pharmaceutical innovation and its pivotal role in advancing ADME testing technologies.

Competitor Landscape

Some of the key companies operating in the ADME toxicology testing market are

  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Catalent, Inc
  • Charles River Laboratories
  • Curia Global, Inc.
  • Dassault Systemes
  • Eurofins Discovery
  • Labcorp Drug Development
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Other Industry Participants

Global ADME Toxicology Testing Market Summary

 

 

Report Specifications Details
Market Revenue in 2022 US$ 8.48 Bn
Market Size Forecast by 2031 US$ 19.78 Bn
Growth Rate (CAGR) 10.5%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Technology, By Application, By Method
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Agilent Technologies, Inc., Beckman Coulter, Inc., Catalent, Inc, Charles River Laboratories, Curia Global, Inc., Dassault Systemes, Eurofins Discovery, Labcorp Drug Development, Promega Corporation, Thermo Fisher Scientific Inc., Other Market Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free): +81 663-386-8111

South Korea (Toll-Free): +82-808-703-126

Saudi Arabia (Toll-Free): +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

 

Global ADME Toxicology Testing Market

By Technology

  • Cell Culture
  • High Throughput
  • Molecular Imaging
  • OMICS Technology

By Application

  • Systemic Toxicity
  • Renal Toxicity
  • Hepatotoxicity
  • Neurotoxicity
  • Other Toxicities

By Method

  • Cellular Assay
  • Biochemical Assay
  • In-Silica
  • Ex-vivo

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Report Coverage & Deliverables

Common

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 - 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of ADME Toxicology Testing Market
6.Market Synopsis: ADME Toxicology Testing Market
7.ADME Toxicology Testing Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in ADME Toxicology Testing Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: ADME Toxicology Testing Market
7.6.Impact of Covid-19 on ADME Toxicology Testing Market
8.Global ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
8.1.Overview
8.1.1.Global ADME Toxicology Testing Market Revenue (US$ Mn)
8.2.Global ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
8.2.1.Cell Culture
8.2.1.1.Definition
8.2.1.2.Market Estimation and Penetration, 2015 - 2022
8.2.1.3.Market Forecast, 2023 - 2031
8.2.1.4.Compound Annual Growth Rate (CAGR)
8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2015 - 2022
8.2.1.5.1.2.Market Forecast, 2023 - 2031
8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2015 - 2022
8.2.1.5.2.2.Market Forecast, 2023 - 2031
8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2015 - 2022
8.2.1.5.3.2.Market Forecast, 2023 - 2031
8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2015 - 2022
8.2.1.5.4.2.Market Forecast, 2023 - 2031
8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2015 - 2022
8.2.1.5.5.2.Market Forecast, 2023 - 2031
8.2.2.High Throughput
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 - 2022
8.2.2.3.Market Forecast, 2023 - 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 - 2022
8.2.2.5.1.2.Market Forecast, 2023 - 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 - 2022
8.2.2.5.2.2.Market Forecast, 2023 - 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 - 2022
8.2.2.5.3.2.Market Forecast, 2023 - 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 - 2022
8.2.2.5.4.2.Market Forecast, 2023 - 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 - 2022
8.2.2.5.5.2.Market Forecast, 2023 - 2031
8.2.3.Molecular Imaging
8.2.3.1.Definition
8.2.3.2.Market Estimation and Penetration, 2015 - 2022
8.2.3.3.Market Forecast, 2023 - 2031
8.2.3.4.Compound Annual Growth Rate (CAGR)
8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2015 - 2022
8.2.3.5.1.2.Market Forecast, 2023 - 2031
8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2015 - 2022
8.2.3.5.2.2.Market Forecast, 2023 - 2031
8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2015 - 2022
8.2.3.5.3.2.Market Forecast, 2023 - 2031
8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2015 - 2022
8.2.3.5.4.2.Market Forecast, 2023 - 2031
8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2015 - 2022
8.2.3.5.5.2.Market Forecast, 2023 - 2031
8.2.4.OMICS Technology
8.2.4.1.Definition
8.2.4.2.Market Estimation and Penetration, 2015 - 2022
8.2.4.3.Market Forecast, 2023 - 2031
8.2.4.4.Compound Annual Growth Rate (CAGR)
8.2.4.5.Regional Bifurcation
8.2.4.5.1.North America
8.2.4.5.1.1.Market Estimation, 2015 - 2022
8.2.4.5.1.2.Market Forecast, 2023 - 2031
8.2.4.5.2.Europe
8.2.4.5.2.1.Market Estimation, 2015 - 2022
8.2.4.5.2.2.Market Forecast, 2023 - 2031
8.2.4.5.3.Asia Pacific
8.2.4.5.3.1.Market Estimation, 2015 - 2022
8.2.4.5.3.2.Market Forecast, 2023 - 2031
8.2.4.5.4.Middle East and Africa
8.2.4.5.4.1.Market Estimation, 2015 - 2022
8.2.4.5.4.2.Market Forecast, 2023 - 2031
8.2.4.5.5.Latin America
8.2.4.5.5.1.Market Estimation, 2015 - 2022
8.2.4.5.5.2.Market Forecast, 2023 - 2031
8.3.Key Segment for Channeling Investments
8.3.1.By Technology
9.Global ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
9.1.Overview
9.2.Global ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1.Systemic Toxicity
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 - 2022
9.2.1.3.Market Forecast, 2023 - 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 - 2022
9.2.1.5.1.2.Market Forecast, 2023 - 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 - 2022
9.2.1.5.2.2.Market Forecast, 2023 - 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 - 2022
9.2.1.5.3.2.Market Forecast, 2023 - 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 - 2022
9.2.1.5.4.2.Market Forecast, 2023 - 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 - 2022
9.2.1.5.5.2.Market Forecast, 2023 - 2031
9.2.2.Renal Toxicity
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2015 - 2022
9.2.2.3.Market Forecast, 2023 - 2031
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 - 2022
9.2.2.5.1.2.Market Forecast, 2023 - 2031
9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 - 2022
9.2.2.5.2.2.Market Forecast, 2023 - 2031
9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 - 2022
9.2.2.5.3.2.Market Forecast, 2023 - 2031
9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 - 2022
9.2.2.5.4.2.Market Forecast, 2023 - 2031
9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 - 2022
9.2.2.5.5.2.Market Forecast, 2023 - 2031
9.2.3.Hepatotoxicity
9.2.3.1.Definition
9.2.3.2.Market Estimation and Penetration, 2015 - 2022
9.2.3.3.Market Forecast, 2023 - 2031
9.2.3.4.Compound Annual Growth Rate (CAGR)
9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2015 - 2022
9.2.3.5.1.2.Market Forecast, 2023 - 2031
9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2015 - 2022
9.2.3.5.2.2.Market Forecast, 2023 - 2031
9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2015 - 2022
9.2.3.5.3.2.Market Forecast, 2023 - 2031
9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2015 - 2022
9.2.3.5.4.2.Market Forecast, 2023 - 2031
9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2015 - 2022
9.2.3.5.5.2.Market Forecast, 2023 - 2031
9.2.4.Neurotoxicity
9.2.4.1.Definition
9.2.4.2.Market Estimation and Penetration, 2015 - 2022
9.2.4.3.Market Forecast, 2023 - 2031
9.2.4.4.Compound Annual Growth Rate (CAGR)
9.2.4.5.Regional Bifurcation
9.2.4.5.1.North America
9.2.4.5.1.1.Market Estimation, 2015 - 2022
9.2.4.5.1.2.Market Forecast, 2023 - 2031
9.2.4.5.2.Europe
9.2.4.5.2.1.Market Estimation, 2015 - 2022
9.2.4.5.2.2.Market Forecast, 2023 - 2031
9.2.4.5.3.Asia Pacific
9.2.4.5.3.1.Market Estimation, 2015 - 2022
9.2.4.5.3.2.Market Forecast, 2023 - 2031
9.2.4.5.4.Middle East and Africa
9.2.4.5.4.1.Market Estimation, 2015 - 2022
9.2.4.5.4.2.Market Forecast, 2023 - 2031
9.2.4.5.5.Latin America
9.2.4.5.5.1.Market Estimation, 2015 - 2022
9.2.4.5.5.2.Market Forecast, 2023 - 2031
9.2.5.Other Toxicities
9.2.5.1.Definition
9.2.5.2.Market Estimation and Penetration, 2015 - 2022
9.2.5.3.Market Forecast, 2023 - 2031
9.2.5.4.Compound Annual Growth Rate (CAGR)
9.2.5.5.Regional Bifurcation
9.2.5.5.1.North America
9.2.5.5.1.1.Market Estimation, 2015 - 2022
9.2.5.5.1.2.Market Forecast, 2023 - 2031
9.2.5.5.2.Europe
9.2.5.5.2.1.Market Estimation, 2015 - 2022
9.2.5.5.2.2.Market Forecast, 2023 - 2031
9.2.5.5.3.Asia Pacific
9.2.5.5.3.1.Market Estimation, 2015 - 2022
9.2.5.5.3.2.Market Forecast, 2023 - 2031
9.2.5.5.4.Middle East and Africa
9.2.5.5.4.1.Market Estimation, 2015 - 2022
9.2.5.5.4.2.Market Forecast, 2023 - 2031
9.2.5.5.5.Latin America
9.2.5.5.5.1.Market Estimation, 2015 - 2022
9.2.5.5.5.2.Market Forecast, 2023 - 2031
9.3.Key Segment for Channeling Investments
9.3.1.By Application
10.Global ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
10.1.Overview
10.2.Global ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
10.2.1.Cellular Assay
10.2.1.1.Definition
10.2.1.2.Market Estimation and Penetration, 2015 - 2022
10.2.1.3.Market Forecast, 2023 - 2031
10.2.1.4.Compound Annual Growth Rate (CAGR)
10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2015 - 2022
10.2.1.5.1.2.Market Forecast, 2023 - 2031
10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2015 - 2022
10.2.1.5.2.2.Market Forecast, 2023 - 2031
10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2015 - 2022
10.2.1.5.3.2.Market Forecast, 2023 - 2031
10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2015 - 2022
10.2.1.5.4.2.Market Forecast, 2023 - 2031
10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2015 - 2022
10.2.1.5.5.2.Market Forecast, 2023 - 2031
10.2.2.Biochemical Assay
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2015 - 2022
10.2.2.3.Market Forecast, 2023 - 2031
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2015 - 2022
10.2.2.5.1.2.Market Forecast, 2023 - 2031
10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2015 - 2022
10.2.2.5.2.2.Market Forecast, 2023 - 2031
10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2015 - 2022
10.2.2.5.3.2.Market Forecast, 2023 - 2031
10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2015 - 2022
10.2.2.5.4.2.Market Forecast, 2023 - 2031
10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2015 - 2022
10.2.2.5.5.2.Market Forecast, 2023 - 2031
10.2.3.In-Silica
10.2.3.1.Definition
10.2.3.2.Market Estimation and Penetration, 2015 - 2022
10.2.3.3.Market Forecast, 2023 - 2031
10.2.3.4.Compound Annual Growth Rate (CAGR)
10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2015 - 2022
10.2.3.5.1.2.Market Forecast, 2023 - 2031
10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2015 - 2022
10.2.3.5.2.2.Market Forecast, 2023 - 2031
10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2015 - 2022
10.2.3.5.3.2.Market Forecast, 2023 - 2031
10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2015 - 2022
10.2.3.5.4.2.Market Forecast, 2023 - 2031
10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2015 - 2022
10.2.3.5.5.2.Market Forecast, 2023 - 2031
10.2.4.Ex-vivo
10.2.4.1.Definition
10.2.4.2.Market Estimation and Penetration, 2015 - 2022
10.2.4.3.Market Forecast, 2023 - 2031
10.2.4.4.Compound Annual Growth Rate (CAGR)
10.2.4.5.Regional Bifurcation
10.2.4.5.1.North America
10.2.4.5.1.1.Market Estimation, 2015 - 2022
10.2.4.5.1.2.Market Forecast, 2023 - 2031
10.2.4.5.2.Europe
10.2.4.5.2.1.Market Estimation, 2015 - 2022
10.2.4.5.2.2.Market Forecast, 2023 - 2031
10.2.4.5.3.Asia Pacific
10.2.4.5.3.1.Market Estimation, 2015 - 2022
10.2.4.5.3.2.Market Forecast, 2023 - 2031
10.2.4.5.4.Middle East and Africa
10.2.4.5.4.1.Market Estimation, 2015 - 2022
10.2.4.5.4.2.Market Forecast, 2023 - 2031
10.2.4.5.5.Latin America
10.2.4.5.5.1.Market Estimation, 2015 - 2022
10.2.4.5.5.2.Market Forecast, 2023 - 2031
10.3.Key Segment for Channeling Investments
10.3.1.By Method
11.North America ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
11.1.Overview
11.1.1.North America ADME Toxicology Testing Market Revenue (US$ Mn)
11.2.North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
11.2.1.Cell Culture
11.2.2.High Throughput
11.2.3.Molecular Imaging
11.2.4.OMICS Technology
11.3.North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1.Systemic Toxicity
11.3.2.Renal Toxicity
11.3.3.Hepatotoxicity
11.3.4.Neurotoxicity
11.3.5.Other Toxicities
11.4.North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
11.4.1.Cellular Assay
11.4.2.Biochemical Assay
11.4.3.In-Silica
11.4.4.Ex-vivo
11.5.North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1.U.S
11.5.1.1.U.S ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.1.1.1.Cell Culture
11.5.1.1.2.High Throughput
11.5.1.1.3.Molecular Imaging
11.5.1.1.4.OMICS Technology
11.5.1.2.U.S ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1.Systemic Toxicity
11.5.1.2.2.Renal Toxicity
11.5.1.2.3.Hepatotoxicity
11.5.1.2.4.Neurotoxicity
11.5.1.2.5.Other Toxicities
11.5.1.3.U.S ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
11.5.1.3.1.Cellular Assay
11.5.1.3.2.Biochemical Assay
11.5.1.3.3.In-Silica
11.5.1.3.4.Ex-vivo
11.5.2.Canada
11.5.2.1.Canada ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.2.1.1.Cell Culture
11.5.2.1.2.High Throughput
11.5.2.1.3.Molecular Imaging
11.5.2.1.4.OMICS Technology
11.5.2.2.Canada ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1.Systemic Toxicity
11.5.2.2.2.Renal Toxicity
11.5.2.2.3.Hepatotoxicity
11.5.2.2.4.Neurotoxicity
11.5.2.2.5.Other Toxicities
11.5.2.3.Canada ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
11.5.2.3.1.Cellular Assay
11.5.2.3.2.Biochemical Assay
11.5.2.3.3.In-Silica
11.5.2.3.4.Ex-vivo
11.5.3.Mexico
11.5.3.1.Mexico ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.3.1.1.Cell Culture
11.5.3.1.2.High Throughput
11.5.3.1.3.Molecular Imaging
11.5.3.1.4.OMICS Technology
11.5.3.2.Mexico ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1.Systemic Toxicity
11.5.3.2.2.Renal Toxicity
11.5.3.2.3.Hepatotoxicity
11.5.3.2.4.Neurotoxicity
11.5.3.2.5.Other Toxicities
11.5.3.3.Mexico ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
11.5.3.3.1.Cellular Assay
11.5.3.3.2.Biochemical Assay
11.5.3.3.3.In-Silica
11.5.3.3.4.Ex-vivo
11.5.4.Rest of North America
11.5.4.1.Rest of North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
11.5.4.1.1.Cell Culture
11.5.4.1.2.High Throughput
11.5.4.1.3.Molecular Imaging
11.5.4.1.4.OMICS Technology
11.5.4.2.Rest of North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
11.5.4.2.1.Systemic Toxicity
11.5.4.2.2.Renal Toxicity
11.5.4.2.3.Hepatotoxicity
11.5.4.2.4.Neurotoxicity
11.5.4.2.5.Other Toxicities
11.5.4.3.Rest of North America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
11.5.4.3.1.Cellular Assay
11.5.4.3.2.Biochemical Assay
11.5.4.3.3.In-Silica
11.5.4.3.4.Ex-vivo
11.6.Key Segment for Channeling Investments
11.6.1.By Country
11.6.2.By Technology
11.6.3.By Application
11.6.4.By Method
12.Europe ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
12.1.Overview
12.1.1.Europe ADME Toxicology Testing Market Revenue (US$ Mn)
12.2.Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.2.1.Cell Culture
12.2.2.High Throughput
12.2.3.Molecular Imaging
12.2.4.OMICS Technology
12.3.Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1.Systemic Toxicity
12.3.2.Renal Toxicity
12.3.3.Hepatotoxicity
12.3.4.Neurotoxicity
12.3.5.Other Toxicities
12.4.Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.4.1.Cellular Assay
12.4.2.Biochemical Assay
12.4.3.In-Silica
12.4.4.Ex-vivo
12.5.Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1.France
12.5.1.1.France ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.1.1.1.Cell Culture
12.5.1.1.2.High Throughput
12.5.1.1.3.Molecular Imaging
12.5.1.1.4.OMICS Technology
12.5.1.2.France ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1.Systemic Toxicity
12.5.1.2.2.Renal Toxicity
12.5.1.2.3.Hepatotoxicity
12.5.1.2.4.Neurotoxicity
12.5.1.2.5.Other Toxicities
12.5.1.3.France ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.1.3.1.Cellular Assay
12.5.1.3.2.Biochemical Assay
12.5.1.3.3.In-Silica
12.5.1.3.4.Ex-vivo
12.5.2.The UK
12.5.2.1.The UK ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.2.1.1.Cell Culture
12.5.2.1.2.High Throughput
12.5.2.1.3.Molecular Imaging
12.5.2.1.4.OMICS Technology
12.5.2.2.The UK ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1.Systemic Toxicity
12.5.2.2.2.Renal Toxicity
12.5.2.2.3.Hepatotoxicity
12.5.2.2.4.Neurotoxicity
12.5.2.2.5.Other Toxicities
12.5.2.3.The UK ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.2.3.1.Cellular Assay
12.5.2.3.2.Biochemical Assay
12.5.2.3.3.In-Silica
12.5.2.3.4.Ex-vivo
12.5.3.Spain
12.5.3.1.Spain ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.3.1.1.Cell Culture
12.5.3.1.2.High Throughput
12.5.3.1.3.Molecular Imaging
12.5.3.1.4.OMICS Technology
12.5.3.2.Spain ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1.Systemic Toxicity
12.5.3.2.2.Renal Toxicity
12.5.3.2.3.Hepatotoxicity
12.5.3.2.4.Neurotoxicity
12.5.3.2.5.Other Toxicities
12.5.3.3.Spain ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.3.3.1.Cellular Assay
12.5.3.3.2.Biochemical Assay
12.5.3.3.3.In-Silica
12.5.3.3.4.Ex-vivo
12.5.4.Germany
12.5.4.1.Germany ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.4.1.1.Cell Culture
12.5.4.1.2.High Throughput
12.5.4.1.3.Molecular Imaging
12.5.4.1.4.OMICS Technology
12.5.4.2.Germany ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1.Systemic Toxicity
12.5.4.2.2.Renal Toxicity
12.5.4.2.3.Hepatotoxicity
12.5.4.2.4.Neurotoxicity
12.5.4.2.5.Other Toxicities
12.5.4.3.Germany ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.4.3.1.Cellular Assay
12.5.4.3.2.Biochemical Assay
12.5.4.3.3.In-Silica
12.5.4.3.4.Ex-vivo
12.5.5.Italy
12.5.5.1.Italy ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.5.1.1.Cell Culture
12.5.5.1.2.High Throughput
12.5.5.1.3.Molecular Imaging
12.5.5.1.4.OMICS Technology
12.5.5.2.Italy ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1.Systemic Toxicity
12.5.5.2.2.Renal Toxicity
12.5.5.2.3.Hepatotoxicity
12.5.5.2.4.Neurotoxicity
12.5.5.2.5.Other Toxicities
12.5.5.3.Italy ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.5.3.1.Cellular Assay
12.5.5.3.2.Biochemical Assay
12.5.5.3.3.In-Silica
12.5.5.3.4.Ex-vivo
12.5.6.Nordic Countries
12.5.6.1.Nordic Countries ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.6.1.1.Cell Culture
12.5.6.1.2.High Throughput
12.5.6.1.3.Molecular Imaging
12.5.6.1.4.OMICS Technology
12.5.6.2.Nordic Countries ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1.Systemic Toxicity
12.5.6.2.2.Renal Toxicity
12.5.6.2.3.Hepatotoxicity
12.5.6.2.4.Neurotoxicity
12.5.6.2.5.Other Toxicities
12.5.6.3.Nordic Countries ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.6.3.1.Cellular Assay
12.5.6.3.2.Biochemical Assay
12.5.6.3.3.In-Silica
12.5.6.3.4.Ex-vivo
12.5.6.4.Nordic Countries ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.Denmark
12.5.6.4.2.Finland
12.5.6.4.3.Iceland
12.5.6.4.4.Sweden
12.5.6.4.5.Norway
12.5.7.Benelux Union
12.5.7.1.Benelux Union ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.7.1.1.Cell Culture
12.5.7.1.2.High Throughput
12.5.7.1.3.Molecular Imaging
12.5.7.1.4.OMICS Technology
12.5.7.2.Benelux Union ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1.Systemic Toxicity
12.5.7.2.2.Renal Toxicity
12.5.7.2.3.Hepatotoxicity
12.5.7.2.4.Neurotoxicity
12.5.7.2.5.Other Toxicities
12.5.7.3.Benelux Union ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.7.3.1.Cellular Assay
12.5.7.3.2.Biochemical Assay
12.5.7.3.3.In-Silica
12.5.7.3.4.Ex-vivo
12.5.7.4.Benelux Union ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.Belgium
12.5.7.4.2.The Netherlands
12.5.7.4.3.Luxembourg
12.5.8.Rest of Europe
12.5.8.1.Rest of Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
12.5.8.1.1.Cell Culture
12.5.8.1.2.High Throughput
12.5.8.1.3.Molecular Imaging
12.5.8.1.4.OMICS Technology
12.5.8.2.Rest of Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1.Systemic Toxicity
12.5.8.2.2.Renal Toxicity
12.5.8.2.3.Hepatotoxicity
12.5.8.2.4.Neurotoxicity
12.5.8.2.5.Other Toxicities
12.5.8.3.Rest of Europe ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
12.5.8.3.1.Cellular Assay
12.5.8.3.2.Biochemical Assay
12.5.8.3.3.In-Silica
12.5.8.3.4.Ex-vivo
12.6.Key Segment for Channeling Investments
12.6.1.By Country
12.6.2.By Technology
12.6.3.By Application
12.6.4.By Method
13.Asia Pacific ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
13.1.Overview
13.1.1.Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn)
13.2.Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.2.1.Cell Culture
13.2.2.High Throughput
13.2.3.Molecular Imaging
13.2.4.OMICS Technology
13.3.Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1.Systemic Toxicity
13.3.2.Renal Toxicity
13.3.3.Hepatotoxicity
13.3.4.Neurotoxicity
13.3.5.Other Toxicities
13.4.Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.4.1.Cellular Assay
13.4.2.Biochemical Assay
13.4.3.In-Silica
13.4.4.Ex-vivo
13.5.Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1.China
13.5.1.1.China ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.1.1.1.Cell Culture
13.5.1.1.2.High Throughput
13.5.1.1.3.Molecular Imaging
13.5.1.1.4.OMICS Technology
13.5.1.2.China ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1.Systemic Toxicity
13.5.1.2.2.Renal Toxicity
13.5.1.2.3.Hepatotoxicity
13.5.1.2.4.Neurotoxicity
13.5.1.2.5.Other Toxicities
13.5.1.3.China ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.1.3.1.Cellular Assay
13.5.1.3.2.Biochemical Assay
13.5.1.3.3.In-Silica
13.5.1.3.4.Ex-vivo
13.5.2.Japan
13.5.2.1.Japan ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.2.1.1.Cell Culture
13.5.2.1.2.High Throughput
13.5.2.1.3.Molecular Imaging
13.5.2.1.4.OMICS Technology
13.5.2.2.Japan ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1.Systemic Toxicity
13.5.2.2.2.Renal Toxicity
13.5.2.2.3.Hepatotoxicity
13.5.2.2.4.Neurotoxicity
13.5.2.2.5.Other Toxicities
13.5.2.3.Japan ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.2.3.1.Cellular Assay
13.5.2.3.2.Biochemical Assay
13.5.2.3.3.In-Silica
13.5.2.3.4.Ex-vivo
13.5.3.India
13.5.3.1.India ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.3.1.1.Cell Culture
13.5.3.1.2.High Throughput
13.5.3.1.3.Molecular Imaging
13.5.3.1.4.OMICS Technology
13.5.3.2.India ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1.Systemic Toxicity
13.5.3.2.2.Renal Toxicity
13.5.3.2.3.Hepatotoxicity
13.5.3.2.4.Neurotoxicity
13.5.3.2.5.Other Toxicities
13.5.3.3.India ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.3.3.1.Cellular Assay
13.5.3.3.2.Biochemical Assay
13.5.3.3.3.In-Silica
13.5.3.3.4.Ex-vivo
13.5.4.New Zealand
13.5.4.1.New Zealand ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.4.1.1.Cell Culture
13.5.4.1.2.High Throughput
13.5.4.1.3.Molecular Imaging
13.5.4.1.4.OMICS Technology
13.5.4.2.New Zealand ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1.Systemic Toxicity
13.5.4.2.2.Renal Toxicity
13.5.4.2.3.Hepatotoxicity
13.5.4.2.4.Neurotoxicity
13.5.4.2.5.Other Toxicities
13.5.4.3.New Zealand ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.4.3.1.Cellular Assay
13.5.4.3.2.Biochemical Assay
13.5.4.3.3.In-Silica
13.5.4.3.4.Ex-vivo
13.5.5.Australia
13.5.5.1.Australia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.5.1.1.Cell Culture
13.5.5.1.2.High Throughput
13.5.5.1.3.Molecular Imaging
13.5.5.1.4.OMICS Technology
13.5.5.2.Australia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1.Systemic Toxicity
13.5.5.2.2.Renal Toxicity
13.5.5.2.3.Hepatotoxicity
13.5.5.2.4.Neurotoxicity
13.5.5.2.5.Other Toxicities
13.5.5.3.Australia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.5.3.1.Cellular Assay
13.5.5.3.2.Biochemical Assay
13.5.5.3.3.In-Silica
13.5.5.3.4.Ex-vivo
13.5.6.South Korea
13.5.6.1.South Korea ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.6.1.1.Cell Culture
13.5.6.1.2.High Throughput
13.5.6.1.3.Molecular Imaging
13.5.6.1.4.OMICS Technology
13.5.6.2.South Korea ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1.Systemic Toxicity
13.5.6.2.2.Renal Toxicity
13.5.6.2.3.Hepatotoxicity
13.5.6.2.4.Neurotoxicity
13.5.6.2.5.Other Toxicities
13.5.6.3.South Korea ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.6.3.1.Cellular Assay
13.5.6.3.2.Biochemical Assay
13.5.6.3.3.In-Silica
13.5.6.3.4.Ex-vivo
13.5.7.Southeast Asia
13.5.7.1.Southeast Asia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.7.1.1.Cell Culture
13.5.7.1.2.High Throughput
13.5.7.1.3.Molecular Imaging
13.5.7.1.4.OMICS Technology
13.5.7.2.Southeast Asia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1.Systemic Toxicity
13.5.7.2.2.Renal Toxicity
13.5.7.2.3.Hepatotoxicity
13.5.7.2.4.Neurotoxicity
13.5.7.2.5.Other Toxicities
13.5.7.3.Southeast Asia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.7.3.1.Cellular Assay
13.5.7.3.2.Biochemical Assay
13.5.7.3.3.In-Silica
13.5.7.3.4.Ex-vivo
13.5.7.4.Southeast Asia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.Indonesia
13.5.7.4.2.Thailand
13.5.7.4.3.Malaysia
13.5.7.4.4.Singapore
13.5.7.4.5.Rest of Southeast Asia
13.5.8.Rest of Asia Pacific
13.5.8.1.Rest of Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
13.5.8.1.1.Cell Culture
13.5.8.1.2.High Throughput
13.5.8.1.3.Molecular Imaging
13.5.8.1.4.OMICS Technology
13.5.8.2.Rest of Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
13.5.8.2.1.Systemic Toxicity
13.5.8.2.2.Renal Toxicity
13.5.8.2.3.Hepatotoxicity
13.5.8.2.4.Neurotoxicity
13.5.8.2.5.Other Toxicities
13.5.8.3.Rest of Asia Pacific ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
13.5.8.3.1.Cellular Assay
13.5.8.3.2.Biochemical Assay
13.5.8.3.3.In-Silica
13.5.8.3.4.Ex-vivo
13.6.Key Segment for Channeling Investments
13.6.1.By Country
13.6.2.By Technology
13.6.3.By Application
13.6.4.By Method
14.Middle East and Africa ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
14.1.Overview
14.1.1.Middle East and Africa ADME Toxicology Testing Market Revenue (US$ Mn)
14.2.Middle East and Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.2.1.Cell Culture
14.2.2.High Throughput
14.2.3.Molecular Imaging
14.2.4.OMICS Technology
14.3.Middle East and Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1.Systemic Toxicity
14.3.2.Renal Toxicity
14.3.3.Hepatotoxicity
14.3.4.Neurotoxicity
14.3.5.Other Toxicities
14.4.Middle East and Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.4.1.Cellular Assay
14.4.2.Biochemical Assay
14.4.3.In-Silica
14.4.4.Ex-vivo
14.5.Middle East and Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1.Saudi Arabia
14.5.1.1.Saudi Arabia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.1.1.1.Cell Culture
14.5.1.1.2.High Throughput
14.5.1.1.3.Molecular Imaging
14.5.1.1.4.OMICS Technology
14.5.1.2.Saudi Arabia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1.Systemic Toxicity
14.5.1.2.2.Renal Toxicity
14.5.1.2.3.Hepatotoxicity
14.5.1.2.4.Neurotoxicity
14.5.1.2.5.Other Toxicities
14.5.1.3.Saudi Arabia ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.1.3.1.Cellular Assay
14.5.1.3.2.Biochemical Assay
14.5.1.3.3.In-Silica
14.5.1.3.4.Ex-vivo
14.5.2.UAE
14.5.2.1.UAE ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.2.1.1.Cell Culture
14.5.2.1.2.High Throughput
14.5.2.1.3.Molecular Imaging
14.5.2.1.4.OMICS Technology
14.5.2.2.UAE ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1.Systemic Toxicity
14.5.2.2.2.Renal Toxicity
14.5.2.2.3.Hepatotoxicity
14.5.2.2.4.Neurotoxicity
14.5.2.2.5.Other Toxicities
14.5.2.3.UAE ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.2.3.1.Cellular Assay
14.5.2.3.2.Biochemical Assay
14.5.2.3.3.In-Silica
14.5.2.3.4.Ex-vivo
14.5.3.Egypt
14.5.3.1.Egypt ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.3.1.1.Cell Culture
14.5.3.1.2.High Throughput
14.5.3.1.3.Molecular Imaging
14.5.3.1.4.OMICS Technology
14.5.3.2.Egypt ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1.Systemic Toxicity
14.5.3.2.2.Renal Toxicity
14.5.3.2.3.Hepatotoxicity
14.5.3.2.4.Neurotoxicity
14.5.3.2.5.Other Toxicities
14.5.3.3.Egypt ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.3.3.1.Cellular Assay
14.5.3.3.2.Biochemical Assay
14.5.3.3.3.In-Silica
14.5.3.3.4.Ex-vivo
14.5.4.Kuwait
14.5.4.1.Kuwait ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.4.1.1.Cell Culture
14.5.4.1.2.High Throughput
14.5.4.1.3.Molecular Imaging
14.5.4.1.4.OMICS Technology
14.5.4.2.Kuwait ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1.Systemic Toxicity
14.5.4.2.2.Renal Toxicity
14.5.4.2.3.Hepatotoxicity
14.5.4.2.4.Neurotoxicity
14.5.4.2.5.Other Toxicities
14.5.4.3.Kuwait ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.4.3.1.Cellular Assay
14.5.4.3.2.Biochemical Assay
14.5.4.3.3.In-Silica
14.5.4.3.4.Ex-vivo
14.5.5.South Africa
14.5.5.1.South Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.5.1.1.Cell Culture
14.5.5.1.2.High Throughput
14.5.5.1.3.Molecular Imaging
14.5.5.1.4.OMICS Technology
14.5.5.2.South Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1.Systemic Toxicity
14.5.5.2.2.Renal Toxicity
14.5.5.2.3.Hepatotoxicity
14.5.5.2.4.Neurotoxicity
14.5.5.2.5.Other Toxicities
14.5.5.3.South Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.5.3.1.Cellular Assay
14.5.5.3.2.Biochemical Assay
14.5.5.3.3.In-Silica
14.5.5.3.4.Ex-vivo
14.5.6.Rest of Middle East & Africa
14.5.6.1.Rest of Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
14.5.6.1.1.Cell Culture
14.5.6.1.2.High Throughput
14.5.6.1.3.Molecular Imaging
14.5.6.1.4.OMICS Technology
14.5.6.2.Rest of Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1.Systemic Toxicity
14.5.6.2.2.Renal Toxicity
14.5.6.2.3.Hepatotoxicity
14.5.6.2.4.Neurotoxicity
14.5.6.2.5.Other Toxicities
14.5.6.3.Rest of Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
14.5.6.3.1.Cellular Assay
14.5.6.3.2.Biochemical Assay
14.5.6.3.3.In-Silica
14.5.6.3.4.Ex-vivo
14.6.Key Segment for Channeling Investments
14.6.1.By Country
14.6.2.By Technology
14.6.3.By Application
14.6.4.By Method
15.Latin America ADME Toxicology Testing Market Analysis and Forecasts, 2023 - 2031
15.1.Overview
15.1.1.Latin America ADME Toxicology Testing Market Revenue (US$ Mn)
15.2.Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
15.2.1.Cell Culture
15.2.2.High Throughput
15.2.3.Molecular Imaging
15.2.4.OMICS Technology
15.3.Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1.Systemic Toxicity
15.3.2.Renal Toxicity
15.3.3.Hepatotoxicity
15.3.4.Neurotoxicity
15.3.5.Other Toxicities
15.4.Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
15.4.1.Cellular Assay
15.4.2.Biochemical Assay
15.4.3.In-Silica
15.4.4.Ex-vivo
15.5.Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1.Brazil
15.5.1.1.Brazil ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
15.5.1.1.1.Cell Culture
15.5.1.1.2.High Throughput
15.5.1.1.3.Molecular Imaging
15.5.1.1.4.OMICS Technology
15.5.1.2.Brazil ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1.Systemic Toxicity
15.5.1.2.2.Renal Toxicity
15.5.1.2.3.Hepatotoxicity
15.5.1.2.4.Neurotoxicity
15.5.1.2.5.Other Toxicities
15.5.1.3.Brazil ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
15.5.1.3.1.Cellular Assay
15.5.1.3.2.Biochemical Assay
15.5.1.3.3.In-Silica
15.5.1.3.4.Ex-vivo
15.5.2.Argentina
15.5.2.1.Argentina ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
15.5.2.1.1.Cell Culture
15.5.2.1.2.High Throughput
15.5.2.1.3.Molecular Imaging
15.5.2.1.4.OMICS Technology
15.5.2.2.Argentina ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1.Systemic Toxicity
15.5.2.2.2.Renal Toxicity
15.5.2.2.3.Hepatotoxicity
15.5.2.2.4.Neurotoxicity
15.5.2.2.5.Other Toxicities
15.5.2.3.Argentina ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
15.5.2.3.1.Cellular Assay
15.5.2.3.2.Biochemical Assay
15.5.2.3.3.In-Silica
15.5.2.3.4.Ex-vivo
15.5.3.Rest of Latin America
15.5.3.1.Rest of Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Technology
15.5.3.1.1.Cell Culture
15.5.3.1.2.High Throughput
15.5.3.1.3.Molecular Imaging
15.5.3.1.4.OMICS Technology
15.5.3.2.Rest of Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Application
15.5.3.2.1.Systemic Toxicity
15.5.3.2.2.Renal Toxicity
15.5.3.2.3.Hepatotoxicity
15.5.3.2.4.Neurotoxicity
15.5.3.2.5.Other Toxicities
15.5.3.3.Rest of Latin America ADME Toxicology Testing Market Revenue (US$ Mn) and Forecasts, By Method
15.5.3.3.1.Cellular Assay
15.5.3.3.2.Biochemical Assay
15.5.3.3.3.In-Silica
15.5.3.3.4.Ex-vivo
15.6.Key Segment for Channeling Investments
15.6.1.By Country
15.6.2.By Technology
15.6.3.By Application
15.6.4.By Method
16.Competitive Benchmarking
16.1.Market Share Analysis, 2022
16.2.Global Presence and Growth Strategies
16.2.1.Mergers and Acquisitions
16.2.2.Product Launches
16.2.3.Investments Trends
16.2.4.R&D Initiatives
17.Player Profiles
17.1.Agilent Technologies, Inc.
17.1.1.Company Details
17.1.2.Company Overview
17.1.3.Product Offerings
17.1.4.Key Developments
17.1.5.Financial Analysis
17.1.6.SWOT Analysis
17.1.7.Business Strategies
17.2.Beckman Coulter, Inc.
17.2.1.Company Details
17.2.2.Company Overview
17.2.3.Product Offerings
17.2.4.Key Developments
17.2.5.Financial Analysis
17.2.6.SWOT Analysis
17.2.7.Business Strategies
17.3.Catalent, Inc
17.3.1.Company Details
17.3.2.Company Overview
17.3.3.Product Offerings
17.3.4.Key Developments
17.3.5.Financial Analysis
17.3.6.SWOT Analysis
17.3.7.Business Strategies
17.4.Charles River Laboratories
17.4.1.Company Details
17.4.2.Company Overview
17.4.3.Product Offerings
17.4.4.Key Developments
17.4.5.Financial Analysis
17.4.6.SWOT Analysis
17.4.7.Business Strategies
17.5.Curia Global, Inc.
17.5.1.Company Details
17.5.2.Company Overview
17.5.3.Product Offerings
17.5.4.Key Developments
17.5.5.Financial Analysis
17.5.6.SWOT Analysis
17.5.7.Business Strategies
17.6.Dassault Systemes
17.6.1.Company Details
17.6.2.Company Overview
17.6.3.Product Offerings
17.6.4.Key Developments
17.6.5.Financial Analysis
17.6.6.SWOT Analysis
17.6.7.Business Strategies
17.7.Eurofins Discovery
17.7.1.Company Details
17.7.2.Company Overview
17.7.3.Product Offerings
17.7.4.Key Developments
17.7.5.Financial Analysis
17.7.6.SWOT Analysis
17.7.7.Business Strategies
17.8.Labcorp Drug Development
17.8.1.Company Details
17.8.2.Company Overview
17.8.3.Product Offerings
17.8.4.Key Developments
17.8.5.Financial Analysis
17.8.6.SWOT Analysis
17.8.7.Business Strategies
17.9.Promega Corporation
17.9.1.Company Details
17.9.2.Company Overview
17.9.3.Product Offerings
17.9.4.Key Developments
17.9.5.Financial Analysis
17.9.6.SWOT Analysis
17.9.7.Business Strategies
17.10.Thermo Fisher Scientific Inc.
17.10.1.Company Details
17.10.2.Company Overview
17.10.3.Product Offerings
17.10.4.Key Developments
17.10.5.Financial Analysis
17.10.6.SWOT Analysis
17.10.7.Business Strategies
17.11.Other Market Participants
18.Key Findings

.

**Exclusive for Multi-User and Enterprise User.

Global ADME Toxicology Testing Market

By Technology

 Cell Culture
 High Throughput
 Molecular Imaging
 OMICS Technology

By Application

 Systemic Toxicity
 Renal Toxicity
 Hepatotoxicity
 Neurotoxicity
 Other Toxicities

By Method

 Cellular Assay
 Biochemical Assay
 In-Silica
 Ex-vivo

By Region

 North America (U.S., Canada, Mexico, Rest of North America)
 Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
 Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
 Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
 Latin America (Brazil, Argentina, Rest of Latin America)

**Note: The report covers cross-segmentation analysis by region further into countries

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers. Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues. Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts. Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here's a breakdown of our data validation processes and the stakeholders we engage with during our primary research:
  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.
The forecasts we provide are based on a comprehensive assessment of various factors, including:
  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market's evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market's historical performance.
Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It's crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.    

Procure Comprehensive Study of

Global ADME Toxicology Testing Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top